Journal
ORGANIC & BIOMOLECULAR CHEMISTRY
Volume 14, Issue 28, Pages 6676-6678Publisher
ROYAL SOC CHEMISTRY
DOI: 10.1039/c6ob01101b
Keywords
-
Categories
Funding
- BBSRC
- Pfizer
- EPSRC UK National Mass Spectrometry Facility (NMSF, Swansea)
- MRC
- Leverhulme Trust
- MRC [MR/K005537/1] Funding Source: UKRI
- Biotechnology and Biological Sciences Research Council [1089376] Funding Source: researchfish
- Medical Research Council [MR/K005537/1] Funding Source: researchfish
Ask authors/readers for more resources
The design and synthesis of azogabazine is described, which represents a highly potent (IC50 = 23 nM) photoswitchable antagonist of the GABA(A) receptor. An azologization strategy is adopted, in which a benzyl phenyl ether in a high affinity gabazine analogue is replaced by an azobenzene, with resultant retention of antagonist potency. We show that cycling from blue to UV light, switching between trans and cis isomeric forms, leads to photochemically controlled antagonism of the GABA ion channel.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available